Edwards Lifesciences Corporatio

$86.29

Name : Edwards Lifesciences Corporatio

Sector : Healthcare

Industry: Medical Devices

Mark. Cap: $49,737,555,968.00

EPSttm : 1.68

Edwards Lifesciences Corporatio

$86.29

0.65%

$0.56

EW — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

1.6

Margin Of Safety %

Put/Call OI Ratio

1.03

EPS Next Q Diff

-0.07

EPS Last/This Y

1.16

EPS This/Next Y

0.38

Price

86.31

Target Price

102.17

Analyst Recom

1.63

Performance Q

-4.94

Upside

-56.9%

Beta

0.86

Ticker: EW

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-08-31	EW	90.75	0.93	4.00	42252
2026-09-01	EW	90.74	1.04	0.68	45501
2026-09-02	EW	90.79	1.04	0.64	45778
2026-09-03	EW	89.76	1.04	0.94	45902
2026-09-04	EW	89.9	1.04	0.71	46136
2026-09-08	EW	86.69	1.04	0.53	46346
2026-09-09	EW	86.18	1.03	0.81	46637
2026-09-10	EW	86.76	1.03	0.16	46778
2026-09-11	EW	84.39	0.94	0.14	49522
2026-09-14	EW	85.53	0.93	0.03	49818
2026-09-15	EW	85.75	0.87	0.03	51415
2026-09-16	EW	89.3	0.85	0.10	51984
2026-09-17	EW	88.26	0.81	0.25	54014
2026-09-18	EW	88.25	0.80	0.33	54136
2026-09-21	EW	88.33	1.01	0.30	43898
2026-09-22	EW	88.82	1.01	0.10	44281
2026-09-23	EW	86.81	0.99	9.92	44853
2026-09-24	EW	85.72	1.01	2.47	45372
2026-09-25	EW	86.28	1.03	0.64	45786
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-08-31	EW	90.74	10.0	156.6	3.00
2026-09-01	EW	90.74	10.0	146.1	3.00
2026-09-02	EW	90.83	10.0	358.3	3.00
2026-09-03	EW	89.86	10.0	335.4	3.00
2026-09-04	EW	89.91	10.0	359.3	3.00
2026-09-08	EW	86.71	10.0	286.1	3.00
2026-09-09	EW	86.00	10.0	339.8	3.00
2026-09-10	EW	86.75	10.0	369.4	3.00
2026-09-11	EW	84.39	10.0	301.9	3.00
2026-09-14	EW	85.52	10.0	383.4	3.00
2026-09-15	EW	85.72	10.0	360.9	3.00
2026-09-16	EW	85.72	10.0	360.9	3.00
2026-09-17	EW	88.23	10.0	333.0	3.00
2026-09-18	EW	88.27	10.0	356.7	3.00
2026-09-21	EW	88.33	10.0	357.9	3.00
2026-09-22	EW	88.81	10.0	366.8	3.00
2026-09-23	EW	86.82	10.0	312.6	3.00
2026-09-24	EW	85.72	10.0	331.2	3.00
2026-09-25	EW	86.31	10.0	369.7	3.00
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-08-31	EW	-2.71	1.28	1.80
2026-09-01	EW	-2.71	1.28	1.80
2026-09-02	EW	-2.71	1.28	1.80
2026-09-03	EW	-2.56	1.28	1.80
2026-09-04	EW	-2.56	1.28	1.80
2026-09-08	EW	-2.56	1.44	1.80
2026-09-09	EW	-2.56	1.44	1.80
2026-09-10	EW	-2.56	1.44	1.80
2026-09-11	EW	-2.56	1.44	1.58
2026-09-14	EW	-2.38	1.43	1.58
2026-09-15	EW	-2.38	1.43	1.58
2026-09-16	EW	-2.38	1.43	1.58
2026-09-17	EW	-2.38	1.43	1.58
2026-09-18	EW	-2.38	1.43	1.58
2026-09-21	EW	-2.38	1.42	1.58
2026-09-23	EW	-2.38	1.42	1.58
2026-09-24	EW	-2.38	1.42	1.58
2026-09-25	EW	-2.38	1.42	1.60
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

0.78

Avg. EPS Est. Current Quarter

0.74

Avg. EPS Est. Next Quarter

0.71

Insider Transactions

-2.38

Institutional Transactions

1.42

Beta

0.86

Average Sales Estimate Current Quarter

1677

Average Sales Estimate Next Quarter

1700

Fair Value

90.03

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

34.5

Max Drawdown 5-Year %

-54.3

Target Price

102.17

P/E

51.21

Forward P/E

25.49

PEG

1.82

P/S

7.64

P/B

4.69

P/Free Cash Flow

34.7

EPS

1.69

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

3.38

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

15.05

Relative Volume

0.89

Return on Equity vs Sector %

-16.8

Return on Equity vs Industry %

-2

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

369.7

◆ EW Healthcare

$86.30

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

14/20

Pullback

19/25

Volume

7/15

Valuation

16/20

TP/AR

1/10

Options

3/10

RSI

42.9

Range 1M

26.8%

Sup Dist

1.3%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

7/25

Growth

14/30

Estimates

5/20

Inst/Vol

4/15

Options

5/10

EPS Yr

17.2%

EPS NY

12.8%

52W%

58.2%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🔴 SELL -1.9% upside

Quality

9/30

Valuation

4/30

Growth

12/25

Stability

9/10

LT Trend

1/5

Upside

-1.9%

Quality

MoS

EW — P/E HistoricalMedical Devices

Edwards Lifesciences Corporatio

Sector: Healthcare

Industry: Medical Devices

Employees: 16000

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Latest News

—

Caricamento notizie per EW…

stock quote shares EW – Edwards Lifesciences Corporation Stock Price stock today

news today EW – Edwards Lifesciences Corporation stock forecast ,stock prediction 2023 2024 2025

marketwatch EW – Edwards Lifesciences Corporation yahoo finance google finance

stock history EW – Edwards Lifesciences Corporation invest stock market

stock prices EW premarket after hours

ticker EW fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: EW

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y